Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Tissue Regenix bolsters board with Consort chief

Jonathan Glenn has run inhaler specialist Consort since 2007 and previously held senior financial roles across the medical industry
Tissue Regenix bolsters board with Consort chief
Tissue Regenix has patented a cell-washing technology

Regenerative med-tech Tissue Regenix (LON:TRX) has appointed the chief executive of Consort Medical to its board as a non-executive.

Jonathan Glenn has run inhaler specialist Consort since 2007 and previously held senior financial roles across the medical industry including seven years at Celltech where he played a key role in the acquisitions of Chiroscience, Medeva and OGS.

John Samuel, Tissue Regenix’s chairman, he was very pleased Glenn was joining the business.

“He has excellent experience in the medical devices market.”

Tissue Regenix has patented a cell-washing technology that it is using to pioneer replacement body parts including skin, knee cartilages, ligaments and heart valves.

PhilW.jpg
Why Invest In Tissue Regenix Group PLC? Read More Here

Register here to be notified of future TRX Company articles
View full TRX profile View Profile

Tissue Regenix Group PLC Timeline

Related Articles

eye-766166_1280_583251a48f148.jpg
November 21 2016
The flagship product, CardioCel, is a bio-engineered tissue scaffold used in the heart valve repair market.
The Hydroponics Company Ltd issued a cannabis research licence
July 11 2017
The licence allows Canndeo to build its exclusive Plant Breeders Rights.
Novogen: Access latest PPT from Proactive's CEO Sessions
April 13 2017
Dr James Garner talked clinical-stage programs with investors.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use